Harvard Medical School researcher Thomas Michel, about why he planned to participate in the April 22 March for Science in Boston (April 21) —Rush Holt, CEO of the American Association for the ...

Penny Stock Kezar Life Sciences Rejects Acquisition Deal From Concentra Biosciences At $1.10/Share, Shelves Mid-Stage Lupus Nephritis Study Kezar Life Sciences halted its PALIZADE Phase 2b lupus ...

Anavex Life Sciences (NASDAQ:AVXL) is a short-squeeze candidate because its share prices are rising on good news, institutional and analyst support is growing, and the short-sellers are selling ...